Other Events ·
AVITA Medical, Inc. held its 2026 Annual Meeting of Stockholders on June 3, 2026, where shareholders elected seven…
AVHHLAVITA Medical, Inc.
AVITA Medical, Inc. held its 2026 Annual Meeting of Stockholders on June 3, 2026, where shareholders elected seven directors and ratified Grant Thornton LLP as the independent auditor. Stockholders approved increasing the non-executive director cash fee pool from $750,000 to $900,000 per annum, as well as various equity grants for directors. Additionally, the company received approval to issue warrants for up to 650,000 shares to Perceptive Credit Holdings V, LP and to issue equity securities up to an additional 10% of issued capital per ASX Listing Rule 7.1A.